You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

DIABINESE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Diabinese patents expire, and what generic alternatives are available?

Diabinese is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in DIABINESE is chlorpropamide. There are eleven drug master file entries for this compound. Additional details are available on the chlorpropamide profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DIABINESE?
  • What are the global sales for DIABINESE?
  • What is Average Wholesale Price for DIABINESE?
Summary for DIABINESE
Drug patent expirations by year for DIABINESE
Recent Clinical Trials for DIABINESE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
NovartisPhase 2

See all DIABINESE clinical trials

US Patents and Regulatory Information for DIABINESE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer DIABINESE chlorpropamide TABLET;ORAL 011641-003 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pfizer DIABINESE chlorpropamide TABLET;ORAL 011641-006 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.